Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 6, 2014, Pages 590-595

  Heldman, Dustin A ^a   Espay, Alberto J ^b   LeWitt, Peter A ^c   Giuffrida, Joseph P ^a  

^a Great Lakes NeuroTechnologies Inc   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bradykinesia; Kinesia; Parkinson's disease; Tremor; UPDRS

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; FEMALE; FINGER TAPPING TEST; HUMAN; INDEX FINGER; KINEMATICS; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE ENDING; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSORY AID; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE; TEST RETEST RELIABILITY; TREATMENT RESPONSE; TREMOR; WIRELESS COMMUNICATION; BIOMECHANICS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HYPOKINESIA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR DISORDERS; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VIDEORECORDING;

ADULT; AGED; BIOMECHANICAL PHENOMENA; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOKINESIA; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR DISORDERS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TREMOR; VIDEO RECORDING;

EID: 84900014604     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.02.022     Document Type: Article

References (41)

1. Giuffrida J.P., Riley D., Maddux B., Heldman D.A. Clinically deployable kinesia technology for automated tremor assessment. Mov Disord 2009, 24(5):723-730.
2. Heldman D.A., Giuffrida J.P., Chen R., Payne M., Mazzella F., Duker A.P., et al. The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures. Mov Disord 2011, 26(10):1859-1863.
3. Heldman D.A., Jankovic J., Vaillancourt D.E., Prodoehl J., Elble R.J., Giuffrida J.P. Essential tremor quantification during activities of daily living. Park Relat Disord 2011, 17(7):537-542.
4. Mera T.O., Heldman D.A., Espay A.J., Payne M., Giuffrida J.P. Feasibility of home-based automated Parkinson's disease motor assessment. J Neurosci Methods 2012, 203(1):152-156.
5. Mera T.O., Burack M.A., Giuffrida J.P. Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease. J Park Dis 2013, 3(3):399-407.
6. Hoffman J.D., McNames J. Objective measure of upper extremity motor impairment in Parkinson's disease with inertial sensors. 2011 Annual international conference of the IEEE engineering in medicine and biology society 2011, 4378-4381. EMBC.
7. Caligiuri M.P., Tripp R.M. A portable hand-held device for quantifying and standardizing tremor assessment. J Med Eng Technol 2004, 28(6):254-262.
8. Zampieri C., Salarian A., Carlson-Kuhta P., Aminian K., Nutt J.G., Horak F.B. The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease. J Neurol Neurosurg Psychiatry 2010, 81(2):171-176.
9. Patel S., Lorincz K., Hughes R., Huggins N., Growdon J., Standaert D., et al. Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors. IEEE Trans Inf Technol Biomed 2009, 13(6):864-873.
10. Hauser R.A., Deckers F., Lehert P. Parkinson's disease home diary: further validation and implications for clinical trials. Mov Disord 2004, 19(12):1409-1413.
11. Ahlskog J.E., Uitti R.J. Rasagiline, Parkinson neuroprotection, and delayed-start trials. Neurology 2010, 74(14):1143-1148.
12. Steffen T., Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-Item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther 2008, 88(6):733-746.
13. Weir J.P. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res Natl Strength Cond Assoc 2005, 19(1):231-240.
14. Papapetropoulos S.S. Patient diaries as a clinical endpoint in Parkinson's disease clinical trials. CNS Neurosci Ther 2012, 18(5):380-387.
15. Maetzler W., Domingos J., Srulijes K., Ferreira J.J., Bloem B.R. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013, 28(12):1628-1637.
16. Pulliam C.L., Eichenseer S.R., Goetz C.G., Waln O., Hunter C.B., Jankovic J., et al. Continuous in-home monitoring of essential tremor. Park Relat Disord 2014, 20(1):37-40.
17. Zampieri C., Salarian A., Carlson-Kuhta P., Nutt J.G., Horak F.B. Assessing mobility at home in people with early Parkinson's disease using an instrumented timed up and go test. Park Relat Disord 2011, 17(4):277-280.
18. Keijsers N.L., Horstink M.W., Gielen S.C. Movement parameters that distinguish between voluntary movements and levodopa-induced dyskinesia in Parkinson's disease. Hum Mov Sci 2003, 22(1):67-89.
19. Horak F.B., Mancini M. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors. Mov Disord 2013, 28(11):1544-1551.
20. Spain R.I., St George R.J., Salarian A., Mancini M., Wagner J.M., Horak F.B., et al. Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed. Gait Posture 2012, 35(4):573-578.
21. Mancini M., Horak F.B., Zampieri C., Carlson-Kuhta P., Nutt J.G., Chiari L. Trunk accelerometry reveals postural instability in untreated Parkinson's disease. Park Relat Disord 2011, 17(7):557-562.
22. Nanhoe-Mahabier W., Allum J.H., Pasman E.P., Overeem S., Bloem B.R. The effects of vibrotactile biofeedback training on trunk sway in Parkinson's disease patients. Park Relat Disord 2012, 18(9):1017-1021.
23. Rochester L., Baker K., Hetherington V., Jones D., Willems A.-M., Kwakkel G., et al. Evidence for motor learning in Parkinson's disease: acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues. Brain Res 2010, 1319:103-111.
24. Elble R.J. Gravitational artifact in accelerometric measurements of tremor. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 2005, 116(7):1638-1643.
25. Temperli P., Ghika J., Villemure J.-G., Burkhard P.R., Bogousslavsky J., Vingerhoets F.J.G. How do parkinsonian signs return after discontinuation of subthalamic DBS?. Neurology 2003, 60(1):78-81.
26. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., et al. Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008, 23(15):2129-2170.
27. Kishore A., Espay A.J., Marras C., Al-Khairalla T., Arenovich T., Asante A., et al. Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesia. Mov Disord 2007, 22(3):328-333.
28. Haley S.M., Fragala-Pinkham M.A. Interpreting change scores of tests and measures used in physical therapy. Phys Ther 2006, 86(5):735-743.
29. Donoghue D., Stokes E.K. How much change is true change? the minimum detectable change of the Berg Balance Scale in elderly people. J Rehabil Med 2009, 41(5):343-346.
30. Quinn G.P., Keough M.J. Experimental design and data analysis for biologists 2002, 199-200. Cambridge University Press.
31. Perkins D.O., Wyatt R.J., Bartko J.J. Penny-wise and pound-foolish: the impact of measurement error on sample size requirements in clinical trials. Biol Psychiatry 2000, 47(8):762-766.
32. Altman D.G., Bland J.M. Measurement in medicine: the analysis of method comparison studies. J R Stat Soc Ser Stat 1983, 32(3):307-317.
33. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 327(8476):307-310.
34. Elm J.J., Goetz C.G., Ravina B., Shannon K., Wooten G.F., Tanner C.M., et al. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol 2005, 57(2):197-203.
35. Kieburtz K. Issues in neuroprotection clinical trials in Parkinson's disease. Neurology 2006, 66(10 Suppl. 4):S50-S57.
36. Bennett D.A., Shannon K.M., Beckett L.A., Goetz C.G., Wilson R.S. Metric properties of nurses' ratings of parkinsonian signs with a modified unified Parkinson's disease rating Scale. Neurology 1997, 49(6):1580-1587.
37. Camicioli R., Grossmann S.J., Spencer P.S., Hudnell K., Anger W.K. Discriminating mild parkinsonism: methods for epidemiological research. Mov Disord 2001, 16(1):33-40.
38. Siderowf A., McDermott M., Kieburtz K., Blindauer K., Plumb S., Shoulson I. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial. Mov Disord 2002, 17(4):758-763.
39. Espay A.J., Beaton D.E., Morgante F., Gunraj C.A., Lang A.E., Chen R. Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. Mov Disord 2009, 24(7):1001-1008.
40. Espay A.J., Giuffrida J.P., Chen R., Payne M., Mazzella F., Dunn E., et al. Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord 2011, 26(14):2504-2508.
41. Metman L.V., Myre B., Verwey N., Hassin-Baer S., Arzbaecher J., Sierens D., et al. Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments. Mov Disord 2004, 19(9):1079-1084.